Jorge Garces, PhD., President & Chief Scientific Officer
Jorge Garces was appointed to the Executive Board effective December 1, 2017.
Jorge Garces, PhD. (46), has over 20 years of management experience in the molecular diagnostics and life sciences industries. Prior to joining Epigenomics, Jorge served as CEO and President of AltheaDx Inc. and previously at Enigma Diagnostics, Inc. in the same capacity. Dr. Garces was also Vice President and Site Operations Manager at Hologic, Inc., where he led the development and submission to FDA for approval of their Cystic Fibrosis and HPV products. Dr. Garces earned his doctorate in Cell and Molecular Biology from the City University of New York and received an MBA from the Kellogg Graduate School of Management at Northwestern University.